Lexeo TherapeuticsLXEO
13F holders, Q1 2024 (March 31)54holders
4famous investors
$15.64avg. 13F price*
At the end of Q1 2024, 54 institutions reported holding Lexeo Therapeutics Inc. (LXEO) in their 13F filings. The largest holders were Eventide Asset Management, LLC ($52.8M), Janus Henderson Group PLC ($39.8M) and D1 Capital Partners ($39.3M). 4 famous investors held it, including Daniel Sundheim (0.6% of D1 Capital Partners's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Lexeo Therapeutics Inc.
- CUSIP
- 52886X107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 27 | $62.6M |
| Exits | 4 | $817K |
Ownership 54 holders
| Eventide Asset Management, LLC | 0.83% | Add +12.2% | 3,369,147 | $52.8M |
| Janus Henderson Group PLC | 0.02% | Add +9.0% | 2,540,785 | $39.8M |
| D1 Capital Partners | 0.60% | No change | 2,506,607 | $39.3M |
| Citadel Advisors | 0.04% | Add +20.1% | 2,502,981 | $38.9M |
| Omega Fund Management, LLC | 23.83% | Add +9.2% | 2,355,904 | $36.9M |
| Novo Holdings A/S | 1.77% | Add +25.3% | 1,638,298 | $25.7M |
| Adage Capital Partners Gp, L.L.C. | 0.04% | New | 1,322,736 | $20.7M |
| Braidwell LP | 1.17% | New | 1,322,277 | $20.7M |
| Artal Group S.A. | 0.32% | Add +32.9% | 801,716 | $12.6M |
| Blackstone Inc. | 0.05% | No change | 696,110 | $10.9M |
| BlackRock Inc. | 0.00% | Add +290.2% | 662,962 | $10.4M |
| Ra Capital Management, L.P. | 0.13% | New | 660,938 | $10.4M |
| Millennium Management | 0.01% | Add +1246.3% | 593,722 | $8.7M |
| Vanguard Group Inc. | 0.00% | Add +15.8% | 481,755 | $7.6M |
| Laurion Capital Management LP | 0.20% | Add +77.9% | 454,182 | $7.1M |
| Geode Capital Management, LLC | 0.00% | Add +97.0% | 197,799 | $3.1M |
| Vestal Point Capital, LP | 0.23% | New | 175,000 | $2.7M |
| Cornell University | 30.03% | New | 126,258 | $2.0M |
| State Street Corp. | 0.00% | New | 112,215 | $1.8M |
| Bank of Montreal | 0.00% | New | 111,186 | $1.8M |
| Northern Trust Corp. | 0.00% | Add +426.7% | 82,101 | $1.3M |
| Verition Fund Management LLC | 0.01% | Reduce -67.8% | 60,843 | $954K |
| Citigroup Inc. | 0.00% | Reduce -46.5% | 49,177 | $771K |
| Jane Street Group, LLC | 0.00% | Add +2.5% | 39,933 | $626K |
| Bank of New York Mellon Corp | 0.00% | Add +100.7% | 28,323 | $444K |
| Charles Schwab Investment Management Inc. | 0.00% | New | 27,361 | $429K |
| Goldman Sachs Group Inc. | 0.00% | New | 23,559 | $369K |
| Barclays PLC | 0.00% | Add +47.8% | 22,929 | $360K |
| Jump Financial, LLC | 0.01% | New | 14,894 | $234K |
| Renaissance Technologies | 0.00% | New | 14,576 | $229K |
| Morgan Stanley | 0.00% | Add +47.0% | 13,944 | $219K |
| Nuveen Asset Management, LLC | 0.00% | New | 13,478 | $211K |
| Woodline Partners LP | 0.00% | New | 12,051 | $189K |
| Susquehanna International Group, LLP | 0.00% | New | 12,041 | $189K |
| UBS Group AG | 0.00% | New | 10,367 | $163K |
| Caxton Corp. | 0.92% | No change | 10,319 | $162K |
| Rhumbline Advisers | 0.00% | New | 9,730 | $153K |
| JPMorgan Chase & Co. | 0.00% | Add +5215.2% | 5,953 | $93K |
| MetLife Investment Management, LLC | 0.00% | New | 5,821 | $91K |
| Bank of America Corp. | 0.00% | Reduce -35.1% | 5,271 | $83K |
| American International Group, Inc. | 0.00% | New | 5,053 | $79K |
| BNP Paribas Financial Markets | 0.00% | New | 4,781 | $75K |
| New York State Common Retirement Fund | 0.00% | New | 4,100 | $64K |
| Wells Fargo & Company | 0.00% | Add +4579.2% | 3,369 | $53K |
| STRS Ohio | 0.00% | New | 1,800 | $28K |
| California State Teachers Retirement System | 0.00% | New | 1,031 | $16K |
| Ameritas Investment Partners, Inc. | 0.00% | New | 1,023 | $16K |
| Legal & General Group Plc | 0.00% | Reduce -94.3% | 863 | $14K |
| Amalgamated Bank | 0.00% | New | 623 | $10K |
| Metropolitan Life Insurance Co | 0.00% | New | 599 | $9K |
| Catalyst Funds Management Pty Ltd | 0.00% | — | 531 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -66.0% | 507 | $8K |
| Royal Bank of Canada | 0.00% | New | 351 | $6K |
| FMR LLC | 0.00% | New | 13 | $204 |
"% of holder's portfolio" is LXEO's weight in each manager's 13F, not the share of Lexeo Therapeutics Inc. the manager owns.